When did OnKure Therapeutics, Inc. report Q4 2024 earnings?

OnKure Therapeutics, Inc. (OKUR) reported Q4 2024 earnings on March 10, 2025 before market open.

What were OnKure Therapeutics, Inc.'s Q4 2024 revenue and EPS?

OnKure Therapeutics, Inc. reported revenue of - and eps of $-1.37 for Q4 2024.

Did OnKure Therapeutics, Inc. beat estimates in Q4 2024?

EPS missed the consensus estimate of $-0.86 by $0.51.

Where can I find OnKure Therapeutics, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-036252) directly on SEC EDGAR. The filing index links above go to sec.gov.

OnKure Therapeutics, Inc. OKUR Q4 2024 Annual earnings

Reported March 10, 2025 · Before market open

Revenue-

EPS-$1.37Miss by $0.51

EPS estimate-$0.86

Next report

Aug 11, 2026 (In 1 week)

Revenue estimate$166.7K

EPS estimate-$0.58

Financials

Q4 2024

Income statement

See full

Revenue-—

Operating income-$18.7M—

Net income-$17.4M—

Balance sheet

See full

Cash & equivalents$110.8M+271%

Total debt$1.1M+61.0%

Total equity$103.8M+202%

Total assets$114.9M+222%

Cash flow

See full

Operating cash flow-$23.4M—

CapEx$15.0K-70.0%

Free cash flow-$23.4M—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$361.23M—

Enterprise value$251.55M—

Returns & leverage

See full

Debt / equity0×—

Current ratio10.7×+6.1×

Versus estimates

Diluted EPS

Q1 2026-$1.11Miss by $0.30 Q4 2025-$0.99Beat by $0.16 Q3 2025-$1.09Beat by $0.11 Q2 2025-$1.14Beat by $0.09 Q1 2025-$1.19Beat by $0.13

Q4 2024-$1.37Miss by $0.51

Ask the moment OnKure Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did OnKure Therapeutics, Inc. report Q4 2024 earnings?: OnKure Therapeutics, Inc. (OKUR) reported Q4 2024 earnings on March 10, 2025 before market open.
What were OnKure Therapeutics, Inc.'s Q4 2024 revenue and EPS?: OnKure Therapeutics, Inc. reported revenue of - and eps of $-1.37 for Q4 2024.
Did OnKure Therapeutics, Inc. beat estimates in Q4 2024?: EPS missed the consensus estimate of $-0.86 by $0.51.
Where can I find OnKure Therapeutics, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-036252) directly on SEC EDGAR. The filing index links above go to sec.gov.